Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Yeung

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Magma (New York, N.Y.)|September 8, 2006
Sources of variation in multi-centre brain MTR histogram studies: body-coil transmission eliminates inter-centre differencesP S Tofts, S C A Steens, M Cercignani, et al.
The American Journal of Pathology|August 4, 2001
The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasmsJ L Arbiser, R Yeung, S W Weiss, et al.
Gynecologic Oncology|July 2, 2023
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203Andre Konski, Snehal Deshmukh, Ann H Klopp, et al.
Gynecologic Oncology|May 21, 2019
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapyKaren M Gil, Stephanie L Pugh, Ann H Klopp, et al.
JCO Oncology Advances|May 15, 2025
Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203Kelsey L Corrigan, Rebecca Paulus, Ann H Klopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2020
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 StudyAnamaria R Yeung, Stephanie L Pugh, Ann H Klopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203Ann H Klopp, Anamaria R Yeung, Snehal Deshmukh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III TrialAnamaria R Yeung, Snehal Deshmukh, Ann H Klopp, et al.
Nature Medicine|April 27, 2026
Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trialRavi Thadhani, Thomas F Hiemstra, Manu Vatish, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Magma (New York, N.Y.)|September 8, 2006
Sources of variation in multi-centre brain MTR histogram studies: body-coil transmission eliminates inter-centre differencesP S Tofts, S C A Steens, M Cercignani, et al.
The American Journal of Pathology|August 4, 2001
The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasmsJ L Arbiser, R Yeung, S W Weiss, et al.
Gynecologic Oncology|July 2, 2023
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203Andre Konski, Snehal Deshmukh, Ann H Klopp, et al.
Gynecologic Oncology|May 21, 2019
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapyKaren M Gil, Stephanie L Pugh, Ann H Klopp, et al.
JCO Oncology Advances|May 15, 2025
Patient-Reported Outcomes During Pelvic Radiation Therapy: A Secondary Analysis on Sexual Function From NRG-RTOG 1203Kelsey L Corrigan, Rebecca Paulus, Ann H Klopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2020
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 StudyAnamaria R Yeung, Stephanie L Pugh, Ann H Klopp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2018
Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203Ann H Klopp, Anamaria R Yeung, Snehal Deshmukh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III TrialAnamaria R Yeung, Snehal Deshmukh, Ann H Klopp, et al.
Nature Medicine|April 27, 2026
Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trialRavi Thadhani, Thomas F Hiemstra, Manu Vatish, et al.
Pageof 9